- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03340298
Fiber and Cardiovascular Risk Factors
The Effect of a Weight Reducing Diet Containing Different Sources of Fiber on Cardiovascular Risk Factors in Overweight and Obese Women: A Randomized Feeding Trial
This study was a parallel randomized controlled feeding trial conducted in overweight and obese participants who were attending the Nutrition Clinic in Isfahan, Iran. Inclusion criteria were as follows: women aged 18 to 50 years; body mass index (BMI) 25 kg/m2
; having noncommunicable diseases such as diabetes, hyperlipidemia, and hypertension; having no history of liver and renal disease, hormonal disorders, food allergy, and other special diseases; not taking specific medications affecting weight; willingness to introduce a dietary change to lose weight; and habitual daily consumption of fruits, vegetables, and whole grains. The exclusion criteria were the following: weight loss of more than 10% of body weight within the 6 months before registration in the study; attending a competitive sport; no consumption of fruits, vegetables, or whole grains habitually; abnormal thyroid hormone concentration; intake of drugs or supplementation that could affect energy expenditure or weight; and not following recommended diets or returning for following visits. Recruitment ran from January 2016 to July 2016. The sample size was calculated based on the standard formula (45):
by considering the Type 1 error (a) of 0.05 and Type 2 error (b) of 0.20 (power D 80%). Based on a previous study in Iranian women (46), we used a within-group BMI mean difference (d) of 2.5 kg/m2 and a standard deviation (SD) of 3.2 kg/m2
- Therefore, we needed 25 participants in each group. The study was approved by the research council and ethical committee of the School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran (grant number: 194172). All participants gave written consent before study enrollment. This trial was registered at ClinicalTrial.gov with code NCT03340298. Study design and interventions A randomized feeding trial was designed that aimed to compare the effect of different sources of fibers with low-calorie conventional diets on weight loss, waist circumference (WC), blood pressure, fasting blood glucose (FBS), and lipid profiles in overweight and obese women. Eligible participants were randomly assigned to the three groups after baseline measures of BMI, using a computer-generated random numbers method of randomization. Seventy-five participants who were eligible for the study were randomly divided to one of the three groups ("whole grains" high fiber diet, "fruits and vegetables" high fiber diet, and diet containing "whole grains, fruits, and vegetables") in a 1:1:1 allocation (Figure 2). Participant allocation was stratified by age and BMI. All participants consumed 35 g of fiber per day as follows: in the whole grains group (n D 25), 25 g of fiber from whole grain products and 10 g fiber from fruits and vegetables was to be consumed with the main meals; in the fruits and vegetables group (n D 25), 25 g of fiber from fruits and vegetables and 10 g from whole grain sources was to be consumed with the main meals; and in the whole grains, fruits, and vegetables group, participants were to consume an equal amount of fiber from both sources (17.5 g fiber from whole grains and 17.5 g fiber from fruits and vegetables) with their main meals daily for 10 weeks. The main meals were determined by an expert dietitian, based on the Harris-Benedict formula, considering 0.5 kg weekly weight loss for each participant. The distribution of macronutrients was similar among groups (carbohydrates, 55%; fat, 30%; and protein, 15%) and the number of servings of each food group was estimated and given to participants. Participants in each group were given their allowed food that contained a list of exchangeable foods, food groups, and subgroups (Table 2). All participants were instructed to attend the nutrition clinic to take their intended products. Participants were supplied with the fruits, vegetables, and whole grains for their diet and they consumed these food items under supervision in the nutrition clinic for 10 weeks. Other components of their weight loss diets, such as dairy, meats/alternatives, and fat groups were asked to be consumed in a free-living situation. To assess compliance of participants' intake of weight loss diets, participants were asked to record their 24-hour food intakes for 3 d/wk during weeks 2, 5, and 10 of the trial. Duration of all physical activities was collected, similar to dietary intakes. To obtain the metabolic equivalent for daily physical activity, the recorded physical activities were multiplied by the relevant metabolic equivalents task hours per day (MET-h/d) to give the MET-h/d values.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
overweight or obese
Exclusion Criteria:
have any diseases
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: grain
25 gram fiber from whole grain products and 10 gram fiber from fruits and vegetables
|
the intervention of different sources of dietary fibers
|
Experimental: fruits and vegetables
25 gram fiber from fruits and vegetables as main supplier and the remaining 10 grams from whole grain sources
|
the intervention of different sources of dietary fibers
|
Experimental: grain-fruits and vegetables
17.5 gram fiber from whole grain and 17.5 gram fiber from fruits and vegetables
|
the intervention of different sources of dietary fibers
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change of weight
Time Frame: 10 weeks
|
Weight was measured by using a digital scale to the nearest 100g while participants wearing light clothes ( Seca, Hamburg , Germany)
|
10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change of waist circumference
Time Frame: 10 weeks
|
The narrowest part of Waist was considered for measuring waist circumference where is between the last rib and the iliac crest to the nearest 0.1 cm over light clothing .
|
10 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change of BMI
Time Frame: 10 weeks
|
BMI was calculated as body weight (Kg)/ height 2 (m).We used a standard mercury sphygmomanometer to measure participants
|
10 weeks
|
change of blood pressure
Time Frame: 10 weeks
|
Blood pressure after resting for 15 minutes.
The measurement was performed three times in the sitting position with 1 minute intervals and the average of three measurements was considered as final blood pressure.Systolic blood pressure was defined as the appearance of the first sound and diastolic blood pressure was defined as the disappearance of the sound.(Korotkoff
phase 5).All Subjects were asked to avoid coffee, tea and all caffeine containing materials before blood pressure.
|
10 weeks
|
change of FBS
Time Frame: 10 weeks
|
Fasting blood glucose was measured by enzymatic colorimetric method using glucose oxidase on the day of blood collection.Blood Specimens were centrifuged at 3000 rpm for 10 minutes in order to separate plasma and samples were stored at -70 C until analysis
|
10 weeks
|
change of lipid profiles
Time Frame: 10 weeks
|
Total cholesterol level and serum TG analysis was done using a Selectra 2 auto-analyzer (Vital scientific, Spankeren ,The Netherlands.)
by an enzymetic colorimetric method with cholesterol esterase and cholesterol oxidase and glycerol phosphate oxidase.(Parsazmoun,Tehran
,Iran).
HDL-C determination was done after precipitation of apolipoprotein B containing lipoporotein withphosphotungstic acid.
LDL-C was calculated by Friedewald ´s formula when the TAG level was lower than 400 mg/dl ; otherwise , LDL-C was determined by an enzymatic method
|
10 weeks
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- FIBER
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Risk Factor
-
University of Southern DenmarkRegion of Southern Denmark; Odense Patient Data Explorative Network; ENIGMA Solutions... and other collaboratorsActive, not recruitingCardiovascular Risk Factor | Risk CommunicationDenmark
-
University of Split, School of MedicineCompletedCardiovascular Risk Factor | Lifestyle Risk ReductionCroatia
-
University Hospital, BrestRecruiting
-
University Hospitals Cleveland Medical CenterRecruitingCardiovascular Risk FactorUnited States
-
Northwestern UniversityNorthShore University HealthSystem; Case Western Reserve University; Shirley... and other collaboratorsCompleted
-
University of ArizonaTerminatedCardiovascular Risk FactorUnited States
-
Penn State UniversityCompletedCardiovascular Risk FactorUnited States
-
Clinique BizetCompleted
-
University Hospital, BrestCompleted
-
University of DelawareCompleted
Clinical Trials on fiber
-
Center of Food and Fermentation TechnologiesCompleted
-
University of Texas Southwestern Medical CenterCompletedNon-Insulin-Dependent Diabetes Mellitus
-
Universidade de Passo FundoCompletedDietary Habits | Bowel Dysfunction
-
Wageningen University and ResearchJ. Rettenmaier & Sohne GmbH & Co. KGCompleted
-
Washington University School of MedicineCompletedMicrobial ColonizationUnited States
-
University of Missouri-ColumbiaRecruiting
-
Ultraviolet InterventionsUniversity of MarylandWithdrawnCatheter-Related InfectionsUnited States
-
University of MinnesotaGeneral Mills; Tate and Lyle Ingredients FranceCompleted